The University of Pennsylvania expects to receive $467 million from a German COVID-19 vaccine manufacturer after the pair ...
The Nobel Prize-winning scientific innovation underlying the COVID-19 vaccine proved to be a notable financial boon for the ...
Shares of vaccine makers moved higher early Monday following a CDC report that the U.S. was seeing a significant uptick in ...
The German drugmaker will pay the NIH $791.5 million, while the University of Pennsylvania will get up to $467 million ...
Five years after the start of Covid, we appear to be trying to teach ourselves the lessons of the pandemic the hard way.
Seeking Alpha on MSN10d
BioNTech inks $1B settlements with NIH and Penn to resolve COVID vaccine royalty claimsBioNTech (BNTX) stock slipped after signing $1B deals with NIH and the University of Pennsylvania to resolve COVID vaccine ...
Penn has reached an agreement to resolve a dispute over Covid-19 royalties the Philadelphia university alleged it was owed.
Researchers have discovered that the SARS-CoV-2 spike protein persists in the brain and skull bone marrow for years after ...
Scientists discover that SARS-CoV-2 spike protein remains in the brain and skull bone marrow for years post-infection, ...
BioNTech (BNTX) has reached settlement agreements with the U.S. National Institutes of Health (NIH) and the University of Pennsylvania over royalties tied to its COVID-19 vaccine, resolving ...
The BioNTech Covid-19 vaccine for children may be available in Hong Kong as early as next month after the drug maker this week applied to the government for permission to supply the lower-dosage ...
A third dose of COVID-19 vaccine is beneficial among older Medicare beneficiaries, regardless of prior medically attended COVID-19 diagnoses.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback